MDGL Competitors & Alternatives
Compare Madrigal Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
MDGL
Main Stock$522.23
Tradestie Score
56
Market Cap
$10.01B
Revenue Growth
1.3%
Analyst Upside
+29.1%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$237.64
|
$12.36B | 26.9 | 61 | Compare |
|
EXEL
Exelixis Inc
|
$49.84
|
$11.09B | 16.6 | 61 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$28.55
|
$10.76B | - | 67 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$48.11
|
$10.74B | - | 60 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$49.67
|
$10.53B | 37.3 | 50 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$72.52
|
$10.49B | - | 58 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$65.32
|
$10.22B | - | 53 | Compare |
|
TECH
Bio-Techne Corp.
|
$44.43
|
$9.33B | 61.9 | 52 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$55.12
|
$8.88B | 161.1 | 55 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$67.44
|
$8.77B | 23.6 | 60 | Compare |
More MDGL Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2834)
224 stocks in this industry